The PI3K pathway in B cell metabolism

References

• Acharya M, Sokolovska A, Tam JM, et al. (2016). αv Integrins combine with LC3 and atg5 to regulate toll-like receptor signalling in B cells. Nat Commun 7:10917.
   PubMed Web of Science ®Google Scholar
• Ahn CS, Metallo CM. (2015). Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab 3:1.
   PubMedGoogle Scholar
• Amin RH, Schlissel MS. (2008). Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9:613–22.
   PubMed Web of Science ®Google Scholar
• Anzelon AN, Wu H, Rickert RC. (2003). Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 4:287–94.
   PubMed Web of Science ®Google Scholar
• Argyriou P, Economopoulou P, Papageorgiou S. (2012). The role of mTOR inhibitors for the treatment of B-cell lymphomas. Adv Hematol 2012:435342.
   PubMedGoogle Scholar
• Arnold J, Murera D, Arbogast F, et al. (2015). Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses. Cell Death Differ 23:853–64.
   PubMed Web of Science ®Google Scholar
• Baracho GV, Cato MH, Zhu Z, et al. (2014). PDK1 regulates B cell differentiation and homeostasis. Proc Natl Acad Sci USA 111:9573–8.
   PubMed Web of Science ®Google Scholar
• Baracho GV, Miletic AV, Omori SA, et al. (2011). Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. Curr Opin Immunol 23:178–83.
   PubMed Web of Science ®Google Scholar
• Benhamron S, Tirosh B. (2011). Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells. Eur J Immunol 41:2390–6.
   PubMed Web of Science ®Google Scholar
• Bertolotti M, Sitia R, Rubartelli A. (2012). On the redox control of B lymphocyte differentiation and function. Antioxid Redox Signal 16:1139–49.
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Jacobs SR, Freemerman AJ, et al. (2012). Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma. Proc Natl Acad Sci U S A 109:11818–23.
   PubMed Web of Science ®Google Scholar
• Bhende PM, Park SI, Lim MS, et al. (2010) The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma. Leukemia 24:1781–4.
   PubMed Web of Science ®Google Scholar
• Blair D, Dufort FJ, Chiles TC. (2012). Protein kinase Cbeta is critical for the metabolic switch to glycolysis following B-cell antigen receptor engagement. Biochem J 448:165–9.
   PubMed Web of Science ®Google Scholar
• Brunn GJ, Williams J, Sabers C, et al. (1996). Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. Embo J 15:5256–67.
   PubMed Web of Science ®Google Scholar
• Bruno P, Calastretti A, Priulla M, et al. (2007). Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles. Cell Signal 19:2118–26.
   PubMed Web of Science ®Google Scholar
• Buck MD, O'sullivan D, Pearce EL. (2015). T cell metabolism drives immunity. J Exp Med 212:1345–60.
   PubMed Web of Science ®Google Scholar
• Buzzai M, Bauer DE, Jones RG, et al. (2005). The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 24:4165–73.
   PubMed Web of Science ®Google Scholar
• Calado DP, Sasaki Y, Godinho SA, et al. (2012). The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nat Immunol 13:1092–100.
   PubMed Web of Science ®Google Scholar
• Capasso M, Bhamrah MK, Henley T, et al. (2010). HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol 11:265–72.
   PubMed Web of Science ®Google Scholar
• Caro P, Kishan AU, Norberg E, et al. (2012). Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22:547–60.
   PubMed Web of Science ®Google Scholar
• Caro-Maldonado A, Wang R, Nichols AG, et al. (2014). Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol 192:3626–36.
   PubMed Web of Science ®Google Scholar
• Cato MH, Chintalapati SK, Yau IW, et al. (2011). Cyclin D3 is selectively required for proliferative expansion of germinal center B cells. Mol Cell Biol 31:127–37.
   PubMed Web of Science ®Google Scholar
• Chen M, Hong MJ, Sun H, et al. (2014). Essential role for autophagy in the maintenance of immunological memory against influenza infection. Nat Med 20:503–10.
   PubMed Web of Science ®Google Scholar
• Chen M, Kodali S, Jang A, et al. (2015). Requirement for autophagy in the long-term persistence but not initial formation of memory B cells. J Immunol 194:2607–15.
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu R, et al. (2008). TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205:2397–408.
   PubMed Web of Science ®Google Scholar
• Cho SH, Ahn AK, Bhargava P, et al. (2011). Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family. Proc Natl Acad Sci USA 108:15972–7.
   PubMed Web of Science ®Google Scholar
• Chopra I, Li HF, Wang H, Webster KA. (2012). Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 55:783–94.
   PubMed Web of Science ®Google Scholar
• Ci X, Kuraoka M, wang H, et al. (2015). TSC1 promotes B cell maturation but is dispensable for germinal center formation. PLoS One 10:e0127527.
   Web of Science ®Google Scholar
• Clayton E, Bardi G, Bell SE, et al. (2002). A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196:753–63.
   PubMed Web of Science ®Google Scholar
• Coloff JL, Mason EF, Altman BJ, et al. (2011). Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem 286:5921–33.
   PubMed Web of Science ®Google Scholar
• Conway KL, Kuballa P, Khor B, et al. (2013). ATG5 regulates plasma cell differentiation. Autophagy 9:528–37.
   PubMed Web of Science ®Google Scholar
• Cross DA, Alessi DR, Cohen P, et al. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785–9.
   PubMed Web of Science ®Google Scholar
• Delgado P, Cubelos B, Calleja E, et al. (2009). Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol 10:880–8.
   PubMed Web of Science ®Google Scholar
• Dengler HS, Baracho GV, Omori SA, et al. (2008). Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 9:1388–98.
   PubMed Web of Science ®Google Scholar
• Dil N, Marshall AJ. (2009). Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation. Mol Immunol 46:1970–8.
   PubMed Web of Science ®Google Scholar
• Ding J, Takano T, Gao S, et al. (2000). Syk is required for the activation of Akt survival pathway in B cells exposed to oxidative stress. J Biol Chem 275:30873–7.
   PubMed Web of Science ®Google Scholar
• Dominguez-Sola D, Kung J, Holmes AB, et al. (2015). The FOXO1 transcription factor instructs the germinal center dark zone program. Immunity 43:1064–74.
   PubMed Web of Science ®Google Scholar
• Dominguez-Sola D, Victora GD, Ying CY, et al. (2012). The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13:1083–91.
   PubMed Web of Science ®Google Scholar
• Donahue AC, Fruman DA. (2003). Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J Immunol 170:5851–60.
   PubMed Web of Science ®Google Scholar
• Doughty CA, Bleiman BF, Wagner DJ, et al. (2006). Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107:4458–65.
   PubMed Web of Science ®Google Scholar
• Dufort FJ, Bleiman BF, Gumina MR, et al. (2007). Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J Immunol 179:4953–7.
   PubMed Web of Science ®Google Scholar
• Dufort FJ, Gumina MR, Ta NL, et al. (2014). Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J Biol Chem 289:7011–24.
   PubMed Web of Science ®Google Scholar
• Dunlop EA, Tee AR. (2014). mTOR and autophagy: a dynamic relationship governed by nutrients and energy. Semin Cell Dev Biol 36:121–9.
   PubMed Web of Science ®Google Scholar
• Duvel K, Yecies JL, Menon S, et al. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171–83.
   PubMed Web of Science ®Google Scholar
• El-Najjar I, Barwick T, Avril N, Montoto S. (2012). The role of FDG-PET and bone marrow examination in lymphoma staging. Ann Oncol 23:x89–91.
   PubMed Web of Science ®Google Scholar
• Elstrom RL, Bauer DE, Buzzai M, et al. (2004). Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892–9.
   PubMed Web of Science ®Google Scholar
• Fang X, Yu SX, Lu Y, et al. (2000). Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11960–5.
   PubMed Web of Science ®Google Scholar
• Fang X, Zhou X, Wang X. (2013). Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma. Biomark Res 1:30.
   PubMedGoogle Scholar
• Faubert B, Boily G, Izreig S, et al. (2013). AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 17:113–24.
   PubMed Web of Science ®Google Scholar
• Frauwirth KA, Riley JL, Harris MH, et al. (2002). The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769–77.
   PubMed Web of Science ®Google Scholar
• Fruman DA, Rommel C. (2011). PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic. Cancer Discov 1:562–72.
   PubMed Web of Science ®Google Scholar
• Fruman DA, Rommel C. (2014). PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13:140–56.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Yoshida T, Okada S, et al. (1997). Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 186:439–48.
   PubMed Web of Science ®Google Scholar
• Gao M, Liang J, Lu Y, et al. (2014). Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene 33:745–55.
   PubMed Web of Science ®Google Scholar
• Garcia-Manteiga JM, Mari S, Godejohann M, et al. (2011). Metabolomics of B to plasma cell differentiation. J Proteome Res 10:4165–76.
   PubMed Web of Science ®Google Scholar
• Gerriets VA, Kishton RJ, Nichols AG, et al. (2015). Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest 125:194–207.
   PubMed Web of Science ®Google Scholar
• Goo CK, Lim HY, Ho QS, et al. (2012). PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1. PLoS One 7:e45806.
   PubMed Web of Science ®Google Scholar
• Gopal AK, Kahl BS, De Vos S, et al. (2014). PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med 370:1008–18.
   PubMed Web of Science ®Google Scholar
• Gottlob K, Majewski N, Kennedy S, et al. (2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15:1406–18.
   PubMed Web of Science ®Google Scholar
• Green DR, Galluzzi L, Kroemer G. (2014). Cell biology. Metabolic control of cell death. Science 345:1250256.
   PubMed Web of Science ®Google Scholar
• Gregory MA, QI Y, Hann SR. (2003). Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606–12.
   PubMed Web of Science ®Google Scholar
• Grumont RJ, Strasser A, Gerondakis S. (2002). B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-kappaB regulated c-myc transcription. Mol Cell 10:1283–94.
   PubMed Web of Science ®Google Scholar
• Gulmann C, Espina V, Petricoin E III, et al. (2005). Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 11:5847–55.
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, et al. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30:214–26.
   PubMed Web of Science ®Google Scholar
• Hartmann S, Agostinelli C, Diener J, et al. (2012). GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers. BMC Cancer 12:586.
   PubMed Web of Science ®Google Scholar
• Hasselblom S, Hansson U, Olsson M, et al. (2010). High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Br J Haematol 149:560–8.
   PubMed Web of Science ®Google Scholar
• Herman SE, Gordon AL, Wagner AJ, et al. (2010). Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood 116:2078–88.
   PubMed Web of Science ®Google Scholar
• Hong JY, Hong ME, Choi MK, et al. (2014). The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases. Ann Oncol 25:182–8.
   PubMed Web of Science ®Google Scholar
• Hoshii T, Tadokoro Y, Naka K, et al. (2012). mTORC1 is essential for leukemia propagation but not stem cell self-renewal. J Clin Invest 122:2114–29.
   PubMed Web of Science ®Google Scholar
• Hudak SA, Gollnick SO, Conrad DH, Kehry MR. (1987). Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. Proc Natl Acad Sci USA 84:4606–10.
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Zhu T, et al. (2002). TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4:648–57.
   PubMed Web of Science ®Google Scholar
• Inoki K, Ouyang H, Zhu T, et al. (2006). TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955–68.
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577–90.
   PubMed Web of Science ®Google Scholar
• Jang KJ, Mano H, Aoki K, et al. (2015). Mitochondrial function provides instructive signals for activation-induced B-cell fates. Nat Commun 6:6750.
   PubMed Web of Science ®Google Scholar
• Jellusova J, Miletic AV, CATO MH, et al. (2013). Context-specific BAFF-R signaling by the NF-κB and PI3K pathways. Cell Rep 5:1022–35.
   PubMed Web of Science ®Google Scholar
• Jewell JL, Guan KL. (2013). Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 38:233–42.
   PubMed Web of Science ®Google Scholar
• Jou ST, Carpino N, Takahashi Y, et al. (2002). Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 22:8580–91.
   PubMed Web of Science ®Google Scholar
• Keating R, Hertz T, Wehenkel M, et al. (2013). The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus. Nat Immunol 14:1266–76.
   PubMed Web of Science ®Google Scholar
• Kim YM, Seo YH, Park CB, et al. (2010). Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence. Ann N Y Acad Sci 1201:65–71.
   PubMed Web of Science ®Google Scholar
• Kim YM, Song I, Seo YH, Yoon G. (2013). Glycogen synthase kinase 3 inactivation induces cell senescence through sterol regulatory element binding protein 1-mediated lipogenesis in Chang cells. Endocrinol Metab (Seoul) 28:297–308.
   PubMedGoogle Scholar
• Kojima H, Kobayashi A, Sakurai D, et al. (2010). Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow. J Immunol 184:154–63.
   PubMed Web of Science ®Google Scholar
• Krasnov GS, Dmitriev AA, Lakunina VA, et al. (2013). Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy. Expert Opin Ther Targets 17:1221–33.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. (2012). mTOR signaling in growth control and disease. Cell 149:274–93.
   PubMed Web of Science ®Google Scholar
• Lazorchak AS, Liu D, Facchinetti V, et al. (2010). Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells. Mol Cell 39:433–43.
   PubMed Web of Science ®Google Scholar
• Le A, Lane AN, Hamaker M, et al. (2012). Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 15:110–21.
   PubMed Web of Science ®Google Scholar
• Lee K, Heffington L, Jellusova J, et al. (2013). Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood 122:2369–79.
   PubMed Web of Science ®Google Scholar
• Li Y, He L, Zeng N, et al. (2013). Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling regulates mitochondrial biogenesis and respiration via estrogen-related receptor alpha (ERRalpha). J Biol Chem 288:25007–24.
   PubMed Web of Science ®Google Scholar
• Lill R, Hoffmann B, Molik S, et al. (2012). The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. Biochim Biophys Acta 1823:1491–508.
   PubMed Web of Science ®Google Scholar
• Limon JJ, Fruman DA. (2012). Akt and mTOR in B cell activation and differentiation. Front Immunol 3:228.
   PubMed Web of Science ®Google Scholar
• Limon JJ, So L, Jellbauer S, et al. (2014). mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. Proc Natl Acad Sci USA 111:E5076–85.
   PubMed Web of Science ®Google Scholar
• Liu T, Kishton RJ, Macintyre AN, et al. (2014). Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. Cell Death Dis 5:e1470.
   PubMed Web of Science ®Google Scholar
• Macaulay K, Blair AS, Hajduch E, et al. (2005). Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells. J Biol Chem 280:9509–18.
   PubMed Web of Science ®Google Scholar
• Majchrzak A, Witkowska M, Smolewski P. (2014). Inhibition of the PI3K/Akt/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance. Molecules 19:14304–15.
   PubMed Web of Science ®Google Scholar
• Mayer A, Denanglaire S, Viollet B, et al. (2008). AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. Eur J Immunol 38:948–56.
   PubMed Web of Science ®Google Scholar
• Mcbrayer SK, Cheng JC, Singhal S, et al. (2012). Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. Blood 119:4686–97.
   PubMed Web of Science ®Google Scholar
• Mena NP, Urrutia PJ, Lourido F, et al. (2015). Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 21:92–105.
   PubMed Web of Science ®Google Scholar
• Michalek RD, Gerriets VA, Jacobs SR, et al. (2011a). Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186:3299–303.
   PubMed Web of Science ®Google Scholar
• Michalek RD, Gerriets VA, Nichols AG, et al. (2011b). Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci USA 108:18348–53.
   PubMed Web of Science ®Google Scholar
• Miller BC, Zhao Z, Stephenson LM, et al. (2008). The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 4:309–14.
   PubMed Web of Science ®Google Scholar
• Morbach H, Schickel JN, Cunningham-Rundles C, et al. (2015). CD19 controls Toll-like receptor 9 responses in human B cells. J Allergy Clin Immunol 137:889–98.
   PubMed Web of Science ®Google Scholar
• Nishida Y, Arakawa S, Fujitani K, et al. (2009). Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461:654–8.
   PubMed Web of Science ®Google Scholar
• Nogueira V, Park Y, Chen CC, et al. (2008). Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458–70.
   PubMed Web of Science ®Google Scholar
• Norbury CJ, Zhivotovsky B. (2004). DNA damage-induced apoptosis. Oncogene 23:2797–808.
   PubMed Web of Science ®Google Scholar
• Oestreich KJ, Read KA, Gilbertson SE, et al. (2014). Bcl-6 directly represses the gene program of the glycolysis pathway. Nat Immunol 15:957–64.
   PubMed Web of Science ®Google Scholar
• Oh WJ, Jacinto E. (2011). mTOR complex 2 signaling and functions. Cell Cycle 10:2305–16.
   PubMed Web of Science ®Google Scholar
• Okada T, Maeda A, Iwamatsu A, et al. (2000). BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13:817–27.
   PubMed Web of Science ®Google Scholar
• Omori SA, Cato MH, Anzelon-Mills A, et al. (2006). Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25:545–57.
   PubMed Web of Science ®Google Scholar
• Otero DC, Omori SA, Rickert RC. (2001). Cd19-dependent activation of Akt kinase in B-lymphocytes. J Biol Chem 276:1474–8.
   PubMed Web of Science ®Google Scholar
• Otipoby KL, Sasaki Y, Schmidt-Supprian M, et al. (2008). BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci USA 105:12435–8.
   PubMed Web of Science ®Google Scholar
• Papandreou I, Goliasova T, Denko NC. (2011). Anticancer drugs that target metabolism: is dichloroacetate the new paradigm? Int J Cancer 128:1001–8.
   PubMed Web of Science ®Google Scholar
• Park H, Staehling K, Tsang M, et al. (2012). Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development. Immunity 36:769–81.
   PubMed Web of Science ®Google Scholar
• Patke A, Mecklenbrauker I, Erdjument-Bromage H, et al. (2006). BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 203:2551–62.
   PubMed Web of Science ®Google Scholar
• Patterson HC, Gerbeth C, Thiru P, et al. (2015). A respiratory chain controlled signal transduction cascade in the mitochondrial intermembrane space mediates hydrogen peroxide signaling. Proc Natl Acad Sci USA 112:E5679–88.
   PubMed Web of Science ®Google Scholar
• Pauls SD, Lafarge ST, Landego I, et al. (2012). The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions. Front Immunol 3:224.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Walsh MC, Cejas PJ, et al. (2009). Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460:103–7.
   PubMed Web of Science ®Google Scholar
• Pengo N, Scolari M, Oliva L, et al. (2013). Plasma cells require autophagy for sustainable immunoglobulin production. Nat Immunol 14:298–305.
   PubMed Web of Science ®Google Scholar
• Pfeifer M, Grau M, Lenze D, et al. (2013). PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 110:12420–5.
   PubMed Web of Science ®Google Scholar
• Qin S, Chock PB. (2003). Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt. Biochemistry 42:2995–3003.
   PubMed Web of Science ®Google Scholar
• Ramadani F, Bolland DJ, Garcon F, et al. (2010). The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci Signal 3:ra60.
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Fox CJ, Plas DR, et al. (2003). Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 23:7315–28.
   PubMed Web of Science ®Google Scholar
• Ray JP, Staron MM, Shyer JA, et al. (2015). The interleukin-2-mTORc1 kinase axis defines the signaling, differentiation, and metabolism of T Helper 1 and follicular B helper T cells. Immunity 43:690–702.
   PubMed Web of Science ®Google Scholar
• Reif K, Okkenhaug K, Sasaki T, et al. (2004). Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 173:2236–40.
   PubMed Web of Science ®Google Scholar
• Reth M. (2002). Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3:1129–34.
   PubMed Web of Science ®Google Scholar
• Richards SM, Clark EA. (2009). BCR-induced superoxide negatively regulates B-cell proliferation and T-cell-independent type 2 Ab responses. Eur J Immunol 39:3395–403.
   PubMed Web of Science ®Google Scholar
• Rickert RC. (2013). New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat Rev Immunol 13:578–91.
   PubMed Web of Science ®Google Scholar
• Rickert RC, Rajewsky K, Roes J. (1995). Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352–5.
   PubMed Web of Science ®Google Scholar
• Roberts DJ, Tan-Sah VP, Smith JM, Miyamoto S. (2013). Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem 288:23798–806.
   PubMed Web of Science ®Google Scholar
• Sander S, Chu VT, Yasuda T, et al. (2015). PI3 kinase and FOXO1 transcription factor activity differentially control B cells in the germinal center light and dark zones. Immunity 43:1075–86.
   PubMed Web of Science ®Google Scholar
• Singh DK, Kumar D, Siddiqui Z, et al. (2005). The strength of receptor signaling is centrally controlled through a cooperative loop between Ca2+ and an oxidant signal. Cell 121:281–93.
   PubMed Web of Science ®Google Scholar
• Sommermann TG, O'Neill K, Plas DR, Cahir-McFarland E. (2011). IKKbeta and NF-kappaB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Res 71:7291–300.
   PubMed Web of Science ®Google Scholar
• Srinivasan L, Sasaki Y, Calado DP, et al. (2009). PI3 kinase signals BCR-dependent mature B cell survival. Cell 139:573–86.
   PubMed Web of Science ®Google Scholar
• Sukumar M, Liu J, Ji Y, et al. (2013). Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest 123:4479–88.
   PubMed Web of Science ®Google Scholar
• Surjit M, Lal SK. (2007). Glycogen synthase kinase-3 phosphorylates and regulates the stability of p27kip1 protein. Cell Cycle 6:580–8.
   PubMed Web of Science ®Google Scholar
• Sutherland C, Leighton IA, Cohen P. (1993). Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296:15–9.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Kaisho T, Ohishi M, et al. (2003a). Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 197:657–67.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Kusakai G, Kishimoto A, et al. (2003b). Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem 278:48–53.
   PubMed Web of Science ®Google Scholar
• Tejeda-Munoz N, Robles-Flores M. (2015). Glycogen synthase kinase 3 in Wnt signaling pathway and cancer. IUBMB Life 67:914–22.
   PubMed Web of Science ®Google Scholar
• Tirado-Velez JM, Joumady I, Saez-Benito A, et al. (2012). Inhibition of fatty acid metabolism reduces human myeloma cells proliferation. PLoS One 7:e46484.
   PubMed Web of Science ®Google Scholar
• Tonks NK. (2005). Redox redux: revisiting PTPs and the control of cell signaling. Cell 121:667–70.
   PubMed Web of Science ®Google Scholar
• Tothova Z, Kollipara R, Huntly BJ, et al. (2007). FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128:325–39.
   PubMed Web of Science ®Google Scholar
• Tuveson DA, Carter RH, Soltoff SP, Fearon DT. (1993). CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986–9.
   PubMed Web of Science ®Google Scholar
• Van Der Windt GJ, Everts B, Chang CH, et al. (2012). Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36:68–78.
   PubMed Web of Science ®Google Scholar
• Velez J, Hail N Jr., Konopleva M, et al. (2013). Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells. Front Oncol 3:67.
   PubMedGoogle Scholar
• Vene R, Delfino L, Castellani P, et al. (2010). Redox remodeling allows and controls B-cell activation and differentiation. Antioxid Redox Signal 13:1145–55.
   PubMed Web of Science ®Google Scholar
• Venigalla RK, McGuire VA, Clarke R, et al. (2013). PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development. Embo J 32:1008–22.
   PubMed Web of Science ®Google Scholar
• Victora GD, Schwickert TA, Fooksman DR, et al. (2010). Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143:592–605.
   PubMed Web of Science ®Google Scholar
• Wallace DC, Fan W, Procaccio V. (2010). Mitochondrial energetics and therapeutics. Annu Rev Pathol 5:297–348.
   PubMed Web of Science ®Google Scholar
• Wang RC, Wei Y, An Z, et al. (2012). Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338:956–9.
   PubMed Web of Science ®Google Scholar
• Watanabe-Matsui M, Muto A, Matsui T, et al. (2011). Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood 117:5438–48.
   PubMed Web of Science ®Google Scholar
• Werner M, Hobeika E, Jumaa H. (2010). Role of PI3K in the generation and survival of B cells. Immunol Rev 237:55–71.
   PubMed Web of Science ®Google Scholar
• Wheeler ML, Defranco AL. (2012). Prolonged production of reactive oxygen species in response to B cell receptor stimulation promotes B cell activation and proliferation. J Immunol 189:4405–16.
   PubMed Web of Science ®Google Scholar
• Wicker LS, Boltz RC Jr, Matt V, et al. (1990). Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur J Immunol 20:2277–83.
   PubMed Web of Science ®Google Scholar
• Woodland RT, Fox CJ, Schmidt MR, et al. (2008). Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111:750–60.
   PubMed Web of Science ®Google Scholar
• Yuan HX, Xiong Y, Guan KL. (2013). Nutrient sensing, metabolism, and cell growth control. Mol Cell 49:379–87.
   PubMed Web of Science ®Google Scholar
• Zha H, Raffeld M, Charboneau L, et al. (2004). Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest 84:235–44.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu T, Hua C, et al. (2014). Rictor is required for early B cell development in bone marrow. PLoS One 9:e103970.
   PubMed Web of Science ®Google Scholar
• Zhang S, Pruitt M, Tran D, et al. (2013). B cell-specific deficiencies in mTOR limit humoral immune responses. J Immunol 191:1692–703.
   PubMed Web of Science ®Google Scholar
• Zhang S, Readinger JA, Dubois W, et al. (2011). Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood 117:1228–38.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Altman BJ, Coloff JL, et al. (2007). Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol Cell Biol 27:4328–39.
   PubMed Web of Science ®Google Scholar